The HØIBERG Prize 2019

21 December 2018

The HØIBERG Prize 2019 went to the Antag Therapeutics team: Charlotte Vinther Bertelsen and Daniel Nørgaard Moesby, Elisa Eleftheriou, Peter Ahn Mouritzen, Valdemar Ellegaard Stage for their well-executed business plan.


“The Antag Therapeutics business plan contains all the important elements an investor is looking for. For instance, the venture opportunity, the scientific fundamentals, and the pharmaceutical value chain are thoroughly analyzed and described in the document. This also includes the specific requirements and challenges related to the type of drugs developed. The business plan is very well-written and represents a coherent and convincing piece of work.”

For the 6th time the HØIBERG Prize goes to the team behind the best business plan among the students on the BioBusiness & Innovation Platform (BBIP) course at Copenhagen Business School (CBS). The purpose of the prize is to commend students that manage to translate an invention within the field of life science into entrepreneurship by means of an attention-grabbing business plan. Focus is on whether the business plan is comprehensive, even if the invention behind is complex, well-documented and addresses all aspects – both present and future - of the business.